ClinVar Genomic variation as it relates to human health
NM_003722.5(TP63):c.728G>A (p.Arg243Gln)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_003722.5(TP63):c.728G>A (p.Arg243Gln)
Variation ID: 6528 Accession: VCV000006528.9
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 3q28 3: 189864380 (GRCh38) [ NCBI UCSC ] 3: 189582169 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 8, 2018 Feb 14, 2024 Jun 10, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_003722.5:c.728G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_003713.3:p.Arg243Gln missense NM_001114980.2:c.446G>A MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001108452.1:p.Arg149Gln missense NM_001114978.2:c.728G>A NP_001108450.1:p.Arg243Gln missense NM_001114979.2:c.728G>A NP_001108451.1:p.Arg243Gln missense NM_001114981.2:c.446G>A NP_001108453.1:p.Arg149Gln missense NM_001114982.2:c.446G>A NP_001108454.1:p.Arg149Gln missense NM_001329144.2:c.728G>A NP_001316073.1:p.Arg243Gln missense NM_001329145.2:c.446G>A NP_001316074.1:p.Arg149Gln missense NM_001329146.2:c.191G>A NP_001316075.1:p.Arg64Gln missense NM_001329148.2:c.728G>A NP_001316077.1:p.Arg243Gln missense NM_001329149.2:c.446G>A NP_001316078.1:p.Arg149Gln missense NM_001329150.2:c.191G>A NP_001316079.1:p.Arg64Gln missense NM_001329964.2:c.722G>A NP_001316893.1:p.Arg241Gln missense NC_000003.12:g.189864380G>A NC_000003.11:g.189582169G>A NG_007550.3:g.272635G>A LRG_428:g.272635G>A LRG_428t1:c.728G>A LRG_428p1:p.Arg243Gln Q9H3D4:p.Arg243Gln - Protein change
- R243Q, R149Q, R241Q, R64Q
- Other names
-
R204Q
- Canonical SPDI
- NC_000003.12:189864379:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TP63 | Little evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
701 | 763 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
no assertion criteria provided
|
Oct 15, 1999 | RCV000006901.3 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jun 10, 2023 | RCV000705452.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
May 22, 2022 | RCV002250454.1 | |
Pathogenic (1) |
criteria provided, single submitter
|
Dec 27, 2021 | RCV001804714.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Split hand-foot malformation 4
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002520998.1
First in ClinVar: Jun 03, 2022 Last updated: Jun 03, 2022 |
Comment:
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of … (more)
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.93; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000006528). A different missense change at the same codon (p.Arg243Trp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000006527). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Syndactyly (present)
|
|
Pathogenic
(Dec 27, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002050585.2
First in ClinVar: Jan 08, 2022 Last updated: Mar 04, 2023 |
Comment:
Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect … (more)
Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31050217, 10535733, 28293528, 12939657, 29620206, 26075610, 17224651, 21652629, 33471964, 34401172, 34906519) (less)
|
|
Pathogenic
(Jun 10, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
TP63-Related Spectrum Disorders
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000834450.6
First in ClinVar: Oct 10, 2018 Last updated: Feb 14, 2024 |
Comment:
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the … (more)
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg243 amino acid residue in TP63. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10535733, 12525544, 18626511, 18792980, 20543567, 21078104, 21652629, 23355676, 23463580). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TP63 protein function. ClinVar contains an entry for this variant (Variation ID: 6528). This variant is also known as p.Arg204Gln. This missense change has been observed in individual(s) with autosomal dominant split-hand-split-foot malformation or SHFM and ectrodactyly-ectodermal dysplasia-cleft (EEC) syndrome (PMID: 10535733, 28293528, 29620206). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 243 of the TP63 protein (p.Arg243Gln). (less)
|
|
Pathogenic
(Oct 15, 1999)
|
no assertion criteria provided
Method: literature only
|
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000027097.2
First in ClinVar: Apr 04, 2013 Last updated: Jan 08, 2018 |
Comment on evidence:
In a patient with ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome (EEC3; 604292), Celli et al. (1999) identified a heterozygous arg204-to-gln mutation in the core … (more)
In a patient with ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome (EEC3; 604292), Celli et al. (1999) identified a heterozygous arg204-to-gln mutation in the core element II of the DNA binding domain of TP63. The mutation segregated with the disease and was not found in normal controls. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genetic analysis of a congenital split‑hand/split‑foot malformation 4 pedigree. | Yang X | Molecular medicine reports | 2018 | PMID: 29620206 |
Intermediate Phenotype between ADULT Syndrome and EEC Syndrome Caused by R243Q Mutation in TP63. | Otsuki Y | Plastic and reconstructive surgery. Global open | 2016 | PMID: 28293528 |
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences. | Monti P | Human mutation | 2013 | PMID: 23463580 |
APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations. | Shen J | Proceedings of the National Academy of Sciences of the United States of America | 2013 | PMID: 23355676 |
Differential altered stability and transcriptional activity of ΔNp63 mutants in distinct ectodermal dysplasias. | Browne G | Journal of cell science | 2011 | PMID: 21652629 |
ADULT syndrome caused by a mutation previously associated with EEC syndrome. | Avitan-Hersh E | Pediatric dermatology | 2010 | PMID: 21078104 |
The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes. | Kirschner RD | Cell cycle (Georgetown, Tex.) | 2010 | PMID: 20543567 |
Split hand foot malformation with whorl-like pigmentary pattern: phenotypic expression of somatic mosaicism for the p63 mutation. | Kosaki R | American journal of medical genetics. Part A | 2008 | PMID: 18792980 |
Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes. | Khokhar SK | Cell research | 2008 | PMID: 18626511 |
P63 mutations are not a major cause of non-syndromic split hand/foot malformation. | de Mollerat XJ | Journal of medical genetics | 2003 | PMID: 12525544 |
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. | Celli J | Cell | 1999 | PMID: 10535733 |
click to load more click to collapse |
Text-mined citations for rs121908836 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.